Study details
Enrolling now
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
Northwestern University
NCT IDNCT05056051ClinicalTrials.gov data as of Apr 2026
Target enrollment
200
Study length
about 4.7 years
Ages
18+
Locations
4 sites in CA, CO, IL +1
What this study is about
This trial is testing whether adding WATS-3D tissue sampling to endoscopic procedures improves the detection of recurrent Barrett's esophagus after treatment. The goal is to identify more cases of recurrence early, allowing for earlier re-treatment and potentially preventing progression to esophageal cancer.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use WATS-3D tissue sampling following forceps biopsies
- 2.Use WATS-3D tissue sampling prior to forceps biopsies
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.